Related Experiment Videos

A novel assay for the measurement of Raf-1 kinase activity

C Bondzi1, S Grant, G W Krystal

  • 1Department of Microbiology/Immunology, Medical College of Virginia of Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia, VA 23249, USA.

Oncogene
|October 24, 2000
PubMed

Insights

A new assay simplifies measuring Raf-1 kinase activity by detecting phosphorylated MEK-1. This rapid, sensitive, and specific method improves upon existing techniques for studying the mitogen-activated protein kinase pathway.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Signaling

Background:

  • Raf-1 is a key serine-threonine protein kinase in the mitogen-activated protein kinase (MAPK) pathway.
  • Current in vitro assays for Raf-1 activity, such as 32P incorporation into MEK or coupled assays, suffer from potential lack of specificity and are time-consuming.

Purpose of the Study:

  • To develop a novel, single-step assay for quantifying Raf-1 kinase activity.
  • To improve upon the speed, sensitivity, and specificity of existing Raf-1 activity assays.

Main Methods:

  • A new assay was developed utilizing recombinant MEK-1 phosphorylation.
  • Detection employed an activation-specific MEK antibody recognizing phosphorylation at Ser 217 and Ser 221.
  • The assay was tested for its ability to detect Raf-1 activation mediated by stem cell factor and paclitaxel.

Main Results:

  • The novel assay successfully detected stem cell factor-mediated Raf-1 activation.
  • MEK phosphorylation by immunoprecipitated Raf-1 reached a plateau within 10 minutes and was Raf-1 dependent.
  • A linear correlation was observed between MEK phosphorylation levels and the amount of immunoprecipitated Raf-1.

Conclusions:

  • The developed assay is rapid, sensitive, and specific for measuring Raf-1 kinase activity.
  • This method represents a significant advancement over current techniques for assessing Raf-1 activation.
  • The assay can detect Raf-1 activation induced by both growth factors and chemotherapeutic agents like paclitaxel.

Related Concept Videos